To establish a clinical research network that can design and rapidly implement ICH-compliant, high quality, large-scale, multi-site clinical studies in preparation for and response to outbreaks in SSA.

Site selection for Core Study

The site selection process for clinical sites participating in the ALERRT Core Study began in August 2018. A selection procedure was written and  assessment forms were developed for clinical sites and partners. Out of a total of 27 sites proposed 16 were selected, including 8 in West Africa, 4 in Central Africa and 4 in East Africa. This list was endorsed by the ALERRT Executive Committee at a meeting held on March 19th in Dakar, Senegal.

Region Partners Country Clinical sites
West IRESSEF

Sénégal

Children's Hospital of Diamniadio
West IP Dakar

Sénégal

CHU de Fann/Albert Royer, Dakar
West  ITM Guinee Centre de Santé amélioré de Maferinyah
West IPCI

Côte d'Ivoire

CHR d'Ayamé
West PACCI

Côte d'Ivoire

Urgences, CHU de Treichville, Abidjan
West KCCR Ghana St. Francis Xavier Hospitol, Foso, Ghana
West UBx

Nigéria

Federal Medical Centre of Owo, Ondo State
West MRCG Gambia Clinical Service Department of Fajara 
Centre IP Cameroun Cameroun Centre Hospitalier d'Essos, Yaounde
Centre Université de Yaoundé 1 Cameroun  Obala District Hospital
Centre IP Bangui RCA

Hôpital de District de Sibut

Centre ALIMA RCA Boda district hospital
East IP Madagascar Madagascar  CHU de Befelatanana, Antananarivo 
East IP France Madagascar  HDSS de Moramanga
East BNITM Tanzanie Korogwe District Hospial, Magunga 
East UVRI Uganda Uganda virus research institue clinic, Entebbe